GRIFFINI, SAMANTHA
GRIFFINI, SAMANTHA
DIPARTIMENTO DI MEDICINA INTERNA (attivo dal 01/01/1998 al 27/04/2012)
Rapid genomic analysis for the early identification of complement abnormalities in adults with transplant associated thrombotic microangiopathy
2025 J. Mariotti, S. Bramanti, L. Porcaro, G. Ardissino, M.T. Pagliari, S. Spena, A. Cairo, S. Griffini, B. Sarina, D. Taurino, D. Mannina, C. De Philippis, D. Marchelli, E. Arbustini, M. Urtis, A. Tescari, A. Santoro, F. Peyvandi, M. Cugno
Effects of Antibody Responses to Pre-Existing Coronaviruses on Disease Severity and Complement Activation in COVID-19 Patients
2022 M. Cugno, P.L. Meroni, D. Consonni, S. Griffini, E. Grovetti, C. Novembrino, A. Torri, G. Griffante, M. Gariglio, L. Varani, F. Peyvandi
Eculizumab treatment in atypical hemolytic uremic syndrome: correlation between functional complement tests and drug levels
2022 M. Cugno, V. Capone, S. Griffini, E. Grovetti, G. Pintarelli, L. Porcaro, E. Clementi, G. Ardissino
Kidney transplant in patients with atypical hemolytic uremic syndrome in the anti-C5 era: single-center experience with tailored Eculizumab
2021 G. Ardissino, D. Cresseri, F. Tel, A. Giussani, S. Salardi, M. Sgarbanti, B. Strumbo, S. Testa, V. Capone, S. Griffini, E. Grovetti, M. Cugno, M. Belingheri, C. Tamburello, E.M. Rodrigues, M. Perrone, M. Cardillo, G. Corti, D. Consonni, L. Furian, S. Tedeschi, P. Messa, C. Beretta
IgM Autoantibodies to Complement Factor H in Atypical Hemolytic Uremic Syndrome
2021 M. Cugno, S. Berra, F. Depetri, S. Tedeschi, S. Griffini, E. Grovetti, S. Caccia, D. Cresseri, P. Messa, S. Testa, F. Giglio, F. Peyvandi, G. Ardissino
Consumption of complement in a 26-year-old woman with severe thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination
2021 M. Cugno, P. Macor, M. Giordano, M. Manfredi, S. Griffini, E. Grovetti, L. De Maso, S. Mellone, L. Valenti, D. Prati, S. Bonato, G. Comi, A. Artoni, P.L. Meroni, F. Peyvandi
Relationship between thrombin generation parameters and prothrombin fragment 1 + 2 plasma levels
2021 M. Capecchi, E. Scalambrino, S. Griffini, E. Grovetti, M. Clerici, G. Merati, V. Chantarangkul, M. Cugno, F. Peyvandi, A. Tripodi
Complement activation in patients with COVID-19: a novel therapeutic target
2020 M. Cugno, P.L. Meroni, R. Gualtierotti, S. Griffini, E. Grovetti, A. Torri, M. Panigada, S. Aliberti, F. Blasi, F. Tedesco, F. Peyvandi
Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis
2019 R. Gualtierotti, F. Ingegnoli, M. Boscolo, S. Griffini, E. Grovetti, M. Cugno
Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome: an update
2018 G. Ardissino, F. Tel, M. Sgarbanti, D. Cresseri, A. Giussani, S. Griffini, E. Grovetto, I. Possenti, M. Perrone, S. Testa, F. Paglialonga, P. Messa, M. Cugno
Early endothelial damage in patients with raynaud's phenomenon
2017 R. Gualtierotti, F. Ingegnoli, T. Schioppo, S. Griffini, E. Grovetti, M. Borghi, M. Cugno, P. Meroni
Assessment of Anti-Tissue Type Plasminogen Activator Antibodies in Patients With Prosthetic Heart Valve Thrombosis: The ATA Trial
2016 M. Özkan, M. Kalçık, M.O. Gürsoy, L. Öcal, S. Griffini, S. Karakoyun, M. Yesin, S. Gündüz, M.A. Astarcıoğlu, E. Bayam, S. Cerşit, A.Ç. Aykan, M. Cugno
Prothrombotic biomarkers in patients with rheumatoid arthritis : the beneficial effect of IL-6 receptor blockade
2016 R. Gualtierotti, F. Ingegnoli, S. Griffini, E. Grovetti, P.L. Meroni, M. Cugno
Salvage therapy with high dose Intravenous Immunoglobulins in acquired Von Willebrand Syndrome and unresponsive severe intestinal bleeding
2014 M. Cugno, A. Tedeschi, S.M. Siboni, F. Stufano, F. Depetri, F.M. Franchi, S. Griffini, F. Peyvandi
Anti-t-PA antibodies in acute myocardial infarction after thrombolysis with rt-PA
2010 M. Cugno, R. Castelli, G. Bisiani, S. Griffini, P.L. Meroni
Anti-tumor necrosis factor alpha therapy normalizes fibrinolysis impairment in patients with active rheumatoid arthritis
2010 F. A. Ingegnoli, F. Fantini, S. Griffini, A. Soldi, P. Meroni, M. Cugno
Plasma biomarkers of acute attacks in patients with angioedema due to C1-inhibitor deficiency
2009 M. Cugno, A. Zanichelli, A. Bellatorre, S. Griffini, M. Cicardi
Effetto della terapia con infliximab sui marcatori di infiammazione, coagulazione e fibrinolisi nell’artrite reumatoide
2008 F. Ingegnoli, M. Cugno, V. Galbiati, A. Soldi, E.G. Favalli, S. Griffini, P.L. Meroni, F. Fantini
Activation of inflammation, coagulation and fibrinolysis in patients with Rheumatoid Arthritis : inhibition by Tumor Necrosis Factor alpha blockade
2008 F.A. Ingegnoli, F. Fantini, E.G. Favalli, V. Galbiati, A. Soldi, S. Griffini, E. Bonanni, M. Cugno
Haemostatic and inflammatory biomarkers in patients with active Rheumatoid Arthritis : effects of Tumor Necrosis Factor alpha blockade
2008 F. Ingegnoli, F. Fantini, V. Galbiati, A. Soldi, R. Gualtierotti, S. Griffini, E.G. Favalli, M. Cugno